EP0591395A4 - - Google Patents

Info

Publication number
EP0591395A4
EP0591395A4 EP19920914351 EP92914351A EP0591395A4 EP 0591395 A4 EP0591395 A4 EP 0591395A4 EP 19920914351 EP19920914351 EP 19920914351 EP 92914351 A EP92914351 A EP 92914351A EP 0591395 A4 EP0591395 A4 EP 0591395A4
Authority
EP
European Patent Office
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19920914351
Other versions
EP0591395A1 (en
Inventor
James W. Young
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sunovion Pharmaceuticals Inc
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sepracor Inc filed Critical Sepracor Inc
Publication of EP0591395A1 publication Critical patent/EP0591395A1/en
Publication of EP0591395A4 publication Critical patent/EP0591395A4/xx
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
EP92914351A 1991-06-26 1992-06-25 Methods and compositions for treating emesis, nausea and other disorders using optically pure s(-) ondansetron Withdrawn EP0591395A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US721723 1985-04-10
US72172391A 1991-06-26 1991-06-26
US75080191A 1991-08-27 1991-08-27
PCT/US1992/005377 WO1993000075A1 (en) 1991-06-26 1992-06-25 Methods and compositions for treating emesis, nausea and other disorders using optically pure s(-) ondansetron
US750801 2000-12-28

Publications (2)

Publication Number Publication Date
EP0591395A1 EP0591395A1 (en) 1994-04-13
EP0591395A4 true EP0591395A4 (en) 1994-08-31

Family

ID=27110471

Family Applications (1)

Application Number Title Priority Date Filing Date
EP92914351A Withdrawn EP0591395A1 (en) 1991-06-26 1992-06-25 Methods and compositions for treating emesis, nausea and other disorders using optically pure s(-) ondansetron

Country Status (5)

Country Link
EP (1) EP0591395A1 (en)
JP (1) JPH06509073A (en)
AU (1) AU2254692A (en)
CA (1) CA2112488A1 (en)
WO (1) WO1993000075A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1022025A3 (en) * 1991-06-26 2002-06-05 Sepracor, Inc. Method and compositions for treating emesis nausea and other disorders using optically pure R(+) ondansetron
CN1078465C (en) * 1996-10-10 2002-01-30 沈阳药科大学 Skin-penetrating absorption prepration
US6548082B1 (en) 1999-03-01 2003-04-15 Sepracor Inc. Methods for treating apnea and apnea disorders using optically pure R(+) ondansetron
WO2003037313A2 (en) * 2001-10-31 2003-05-08 Recovery Pharmaceuticals, Inc. Methods for the treatment of addiction
JP5004236B2 (en) * 2005-02-09 2012-08-22 キッセイ薬品工業株式会社 Orally disintegrating tablets
US20110288115A1 (en) * 2010-05-24 2011-11-24 Avmedis Llc Treatment of vagally-mediated spectrum disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695578A (en) * 1984-01-25 1987-09-22 Glaxo Group Limited 1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances
GB8516083D0 (en) * 1985-06-25 1985-07-31 Glaxo Group Ltd Heterocyclic compounds
GB8518745D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Heterocyclic compounds
ES2052585T3 (en) * 1986-12-17 1994-07-16 Glaxo Group Ltd USE OF KETONIC DERIVATIVES IN THE TREATMENT OF COGNITIVE DISORDERS.

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
A.BUTLER ET AL.: "Pharmacological properties of GR38032F, a novel antagonist at 5-HT3 receptors", BR.J.PHARMACOL., vol. 94, 1988, pages 397 - 412 *
A.BUTLER ET AL.: "The pharmacological characterization of 5-HT3 receptors in three isolated preparations derived from guinea -pig tissues", BR.J.PHARMACOL., vol. 101, 1990, pages 591 - 598 *
See also references of WO9300075A1 *

Also Published As

Publication number Publication date
AU2254692A (en) 1993-01-25
EP0591395A1 (en) 1994-04-13
JPH06509073A (en) 1994-10-13
CA2112488A1 (en) 1993-01-07
WO1993000075A1 (en) 1993-01-07

Similar Documents

Publication Publication Date Title
DE9101460U1 (en)
DE9104598U1 (en)
DE9100514U1 (en)
DE9104788U1 (en)
DE9101981U1 (en)
DE9101603U1 (en)
DE9103241U1 (en)
DE9102748U1 (en)
DE9105369U1 (en)
DE9104753U1 (en)
DE9100582U1 (en)
DE9105020U1 (en)
DE9102723U1 (en)
DE9103293U1 (en)
DE9100869U1 (en)
DE9103421U1 (en)
DE9100984U1 (en)
DE9100322U1 (en)
DE9102388U1 (en)
DE9101178U1 (en)
DE9105342U1 (en)
DE9101285U1 (en)
DE9105598U1 (en)
DE9101148U1 (en)
DE9105178U1 (en)

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19940111

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU MC NL SE

A4 Supplementary search report drawn up and despatched
AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU MC NL SE

17Q First examination report despatched

Effective date: 19950117

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19960130